Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001628280-24-006705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | 2024-02-21 | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $17.35 | -87 | 123.9K | -0.1% | -$1,509 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | S | D | 87 | $17.35 | 123,940 | D | — | — |